Owens & Minor (OMI)
(Delayed Data from NYSE)
$16.48 USD
+1.17 (7.64%)
Updated Jul 23, 2024 04:00 PM ET
After-Market: $16.48 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth F Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$16.48 USD
+1.17 (7.64%)
Updated Jul 23, 2024 04:00 PM ET
After-Market: $16.48 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth F Momentum A VGM
Zacks News
Are Investors Undervaluing Owens & Minor (OMI) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Zacks.com featured highlights include: ArcBest, American Airlines, AmerisourceBergen, Owens & Minor and Commercial Metals
by Zacks Equity Research
Zacks.com featured highlights include: ArcBest, American Airlines, AmerisourceBergen, Owens & Minor and Commercial Metals
Zacks.com featured highlights include: Delta Air Lines, Costco Wholesale, Owens & Minor, EOG Resources and JELD-WEN
by Zacks Equity Research
Zacks.com featured highlights include: Delta Air Lines, Costco Wholesale, Owens & Minor, EOG Resources and JELD-WEN
5 Stocks That Look Impressive After Broker Rating Upgrades
by Maharathi Basu
The guidance to design a winning portfolio comes from brokers. Given their thorough know-how pertaining to the stock market, investors often look to be guided by broker advice.
Buy These 5 Top-Ranked Stocks With Upgraded Broker Ratings
by Swayta Shah
After an in-depth research, brokers decide to rate a company's stock. Thus, when they upgrade a stock, you can easily rely on it.
New Strong Buy Stocks for November 7th
by Nitish Marwah
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Thursday
Owens & Minor (OMI) Tops Q3 Earnings Estimates
by Zacks Equity Research
Owens & Minor (OMI) delivered earnings and revenue surprises of 15.79% and -1.62%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Owens & Minor (OMI) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Owens & Minor (OMI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Add ResMed (RMD) to Your Portfolio
by Zacks Equity Research
Investors continue to be optimistic about ResMed's (RMD) performance.
Myriad Genetics Test to Identify Cancer Patients Gets FDA Nod
by Zacks Equity Research
Myriad Genetics (MYGN) moves a step toward advanced treatment by identifying women with ovarian cancer, who are currently receiving chemotherapy.
LabCorp (LH) Q3 Earnings Surpass Estimates, Tapers View
by Zacks Equity Research
LabCorp (LH) impresses investors with third-quarter 2019 results on the robust performance of the Covance Drug Development segment.
Boston Scientific (BSX) Catches Eye: Stock Jumps 5%
by Zacks Equity Research
Boston Scientific (BSX) saw a big move last session, as its shares jumped 5% on the day, amid huge volumes.
Earnings Preview: Owens & Minor (OMI) Q3 Earnings Expected to Decline
by Zacks Equity Research
Owens & Minor (OMI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Here's Why You Should Hold on to Abbott (ABT) Stock for Now
by Zacks Equity Research
Investors continue to be optimistic about Abbott's (ABT) performance.
ResMed Upgrades Nasal Care by Introducing Cradle CPAP Mask
by Zacks Equity Research
ResMed (RMD) revolutionizes sleep apnea treatment by introducing a hassle-free and easy-to-use mask.
Owens & Minor, Acuity Brands, Tesla, Ford and General Motors highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Owens & Minor, Acuity Brands, Tesla, Ford and General Motors highlighted as Zacks Bull and Bear of the Day
Bull Of The Day: Owens and Minor (OMI)
by Brian Bolan
This stock has been on a run of late and it looks like it won't stop until after it makes it to double digits.
Top Ranked Momentum Stocks to Buy for October 21st
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, October 21st
Will Owens & Minor Continue to Surge Higher?
by Zacks Equity Research
As of late, it has definitely been a great time to be an investor Owens & Minor.
Here's Why You Should Hold on to IDEXX (IDXX) Stock for Now
by Zacks Equity Research
Investors continue to be optimistic about IDEXX's (IDXX) performance.
Abbott Forms Alliance With Omada Health for Diabetes Care
by Zacks Equity Research
Abbott (ABT) collaborates with Omada Health to revolutionize diabetes care by expanding technological access.
New Strong Buy Stocks for October 11th
by Tirthankar Chakraborty
Here are 5 stocks added to the Zacks Rank #1 (Strong Buy) List for Friday
Is Owens & Minor (OMI) a Suitable Stock for Value Investors?
by Zacks Equity Research
Let's see if Owens & Minor, Inc. (OMI) stock is a good choice for value-oriented investors right now, or if investors subscribing to this methodology should look elsewhere for top picks.
Owens & Minor (OMI) Q2 Earnings and Revenues Top Estimates
by Zacks Equity Research
Owens & Minor (OMI) delivered earnings and revenue surprises of 42.86% and 2.35%, respectively, for the quarter ended June 2019. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Owens & Minor (OMI) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Owens & Minor (OMI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.